Key result
Angiotensin II had no direct effect on pulmonary blood vessels or systemic vascular capacity in dogs, whereas norepinephrine acted as a pulmonary vasoconstrictor and potent venoconstrictor.
Answers are grounded in this paper and cite their sources.
Canine data warrant no change in human vasopressor selection; leaves open direct pulmonary effects of angiotensin II.
In dog experiments, angiotensin II and norepinephrine were compared in regard to some components of the generalized pressor response each of these agents produces. It was found that angiotensin II has no direct effect on pulmonary blood vessels, in contrast to the pulmonary vasoconstrictor effect of norepinephrine. Angiotensin II appeared to have no effects on veins or the systemic vascular capacity, while norepinephrine was a potent venoconstrictor with, therefore, a marked ability to reduce the systemic vascular capacity.
No takes yet. Share an insight, caveat, or question.
Rose et al. (1962) studied this question. Angiotensin II vs. Norepinephrine was evaluated on Effects on pulmonary circulation, systemic arteries and veins, and systemic vascular capacity. Angiotensin II had no direct effect on pulmonary blood vessels or systemic vascular capacity in dogs, whereas norepinephrine acted as a pulmonary vasoconstrictor and potent venoconstrictor.
Synapse has enriched 10 related papers. Consider them for comparative context: